Kepone
|
CAS
143-50-0
|
C10Cl10O
|
RTECS
PC8575000
|
Synonyms & Trade Names
Chlordecone; Decachlorooctahydro-1,3,4-metheno-2H-cyclobuta(cd)-pentalen-2-one; Decachlorooctahydro-kepone-2-one; Decachlorotetrahydro-4,7-methanoindeneone
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: Ca TWA 0.001 mg/m3 See Appendix A
|
|
OSHA PEL: none
|
IDLH
Ca [N.D.]
See: IDLH INDEX
|
Conversion
|
Physical Description
Tan to white, crystalline, odorless solid. [insecticide]
|
MW: 490.6
|
BP: Sublimes
|
MLT: 662°F (Sublimes)
|
Sol(212°F): 0.5%
|
VP(77°F): 3 x 10-7 mmHg
|
IP: ?
|
|
Sp.Gr: ?
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Solid
|
Incompatibilities & Reactivities
Acids, acid fumes
|
Measurement Methods
NIOSH 5508
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Headache, anxiety, tremor; liver, kidney damage; visual disturbance; ataxia, chest pain, skin erythema (skin redness); testicular atrophy, low sperm count; [potential occupational carcinogen]
|
Target Organs
Eyes, skin, respiratory system, central nervous system, liver, kidneys, reproductive system
Cancer Site
[in animal: liver cancer]
|
